A groundbreaking approach to combat solid tumors using systemic hypoxia as a novel therapeutic strategy. This technology induces a controlled, low-oxygen state in the body—similar to conditions experienced at high altitudes—which creates a metabolic competition between tumors and the host, limiting fuel sources necessary for tumor growth. Currently in the preclinical stage, this approach has demonstrated significant reductions in tumor growth in breast and pancreatic cancer models. Unlike traditional therapies focused on targeting the tumor directly, this invention introduces a paradigm-shifting method by leveraging the body’s natural response to hypoxia.
Patent Pending